N-cycloheptylglycine is an amino acid derivative characterized by the presence of a cycloheptyl group attached to the nitrogen of the glycine molecule. This compound features a simple structure with a carboxylic acid group (-COOH) and an amine group (-NH2), typical of amino acids, along with the cycloheptyl substituent that contributes to its unique properties. N-cycloheptylglycine is known for its potential role in biochemical research, particularly in studies related to neurotransmitter systems and receptor interactions. Its structural characteristics may influence its solubility, stability, and biological activity. The cycloheptyl group can impart hydrophobic properties, which may affect how the molecule interacts with other biological molecules. Additionally, the compound may exhibit interesting pharmacological properties, making it a subject of interest in medicinal chemistry. As with many amino acid derivatives, its synthesis and characterization are important for understanding its potential applications in various fields, including pharmaceuticals and biochemistry.

N-cycloheptylglycine

(cycloheptylamino)acetic acid

Cycloheptylaminoacetic acid is a non-peptide antagonist drug that binds to the β2-adrenergic receptor. It is used in the treatment of cancer, inflammation, and other conditions. Cycloheptylaminoacetic acid has been shown to have a potent annealing effect on DNA, which may be due to its ability to form covalent bonds with guanine residues in DNA. Cycloheptylaminoacetic acid has also been shown to inhibit the binding of β2-adrenergic agonists by displacing them from their receptors. This drug also functions as a carboxylate group and inhibits the function of phosphodiesterase enzymes that are involved in regulating intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).

CAS 82017-41-2: N-cycloheptylglycine

(cycloheptylamino)acetic acid

Ref: IN-DA005E5P

N-cycloheptylglycine

Ref: 10-F311024

(Cycloheptylamino)acetic acid

Ref: 3D-FC115526